The symptomatology of SARS-CoV-2 infection:
from acute symptoms to post-COVID syndrome

published in May - June 2021 - in Il Fisioterapista - issue n.3


  1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol 2020;92(4):401-2.
  2. Jin Y, Yang H, Ji W, et al. Virology, epidemiology, pathogenesis, and control of Covid-19. Viruses. 2020;12(4):372.
  3. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382:1199-207.
  4. World Health Organization (WHO). [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2020;41(2):145-51.
  5. Gorbalenya A, Baker S, Baric R, et al. Severe acute respiratory syndrome-related coronavirus : The species and its viruses – a statement of the Coronavirus Study Group. Nat Microbiol. 2020.
  6. Epicentro ISS. Tutto sulla pandemia di SARS-CoV-2. 2021.
  7. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report 51. 2020.
  8. ISTAT-ISS. Impatto dell’epidemia COVID-19 sulla mortalità totale della popolazione residente anno 2020.
  9. Task force COVID-19 del Dipartimento Malattie Infettive e Servizio di Informatica, Istituto Superiore di Sanità. Epidemia COVID-19, Aggiornamento nazionale: 10 marzo 2021.
  10. Istat. Bes 2020-il benessere equo e sostenibile in italia. 2021.
  11. Epicentro ISS. Il ruolo delle patologie croniche pregresse nella prognosi dei pazienti COVID-19. 2020.
  12. Ye Q, Wang B, Mao J, et al. Epidemiological analysis of COVID-19 and practical experience from China. J Med Virol 2020; 92: 755–69.
  13. Guan W-J, Liang W-H, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. 55(5): 2000547.
  14. Report of the WHO. China joint mission on coronavirus disease 2019 (COVID-19). 2020.
  15. Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to sars-cov-2 infection: illness beyond acute infection and public health implications. JAMA. 2020; 324: 2251–2.
  16. Perego E, Callard F, Stras L, et al. Why the patient-made term ’ Long Covid ’ is needed. 2020; 1–12.
  17. Carfì A, Bernabei R, Landi F, Group GAC-19 P-ACS. Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324: 603–5.
  18. Goërtz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 2020; 6: 00542–2020.
  19. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77: 683–90.
  20. Brugliera L, Spina A, Castellazzi P, et al. Rehabilitation of COVID-19 patients. J Rehabil Med 2020; 52: 2–4.
  21. Gemelli against COVID-19 Post-Acute Care Study Group. Post-COVID-19 global health strategies: the need for an interdisciplinary approach. 2020; 1-8.
  22. Lazzeri M, Lanza A, Bellini R, et al. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: A Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR). Monaldi Arch. Chest Dis. 2020; 90: 163–8.
  23. Kiekens C, Boldrini P, Andreoli A, et al. Rehabilitation and respiratory management in the acute and early post-acute phase ‘instant paper from the field’ on rehabilitation answers to the COVID-19 emergency. Eur J Phys Rehabil Med 2020; 56: 323–6.
  24. Tuzun S, Keles A, Okutan D, Yildiran T, Palamar D. Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19. Eur J Phys Rehabil Med 2021.
  25. Kucuk A, Cumhur Cure M, Cure E. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis. Clin. Rheumatol. 2020; 39: 2103–4.
  26. Kara M, Kaymak B, Ata AM, et al. SONOGRAPHIC THIGH ADJUSTMENT RATIO - STAR A Golden Formula for the Diagnosis of Sarcopenia. Am J Phys Med Rehabil 2020; 99: 902–8.
  27. Ata AM, Kara M, Ekiz T, et al. Reassessing sarcopenia in hypertension: STAR and ACE Inhibitors Excel. Int J Clin Pract 2021; 75.
  28. Cortelezzi A, Tribocco S, Zanoni M, Villa M AA. Presupposti per un protocollo di intervento riabilitativo in pazienti con COVID-19. Medici Oggi 2020.
  29. Iannaccone S, Castellazzi P, Tettamanti A, et al. Role of rehabilitation department for adult individuals with COVID-19: The Experience of the San Raffaele Hospital of Milan. Arch. Phys. Med. Rehabil. 2020; 101(9): 1656–61.
  30. Stam HJ, Stucki G, Bickenbach J. Covid-19 and post intensive care syndrome: A call for action. J Rehabil Med 2020; 52: 19–22.
  31. Yu P, Wei Q, He C. Early rehabilitation for critically Ill patients with COVID-19: more benefits than risks. Am J Phys Med Rehabil. 2020;99(6):468-9.
  32. Dati aggregati quotidiani Regioni/PPAA - Ministero della Salute - Istituto Superiore di Sanità.
  33. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. Preprint. medRxiv. 2021;2021.01.27.21250617. Published 2021 Jan 30.